Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Photodynamic Therapy (PDT) Versus Transpupillary Thermotherapy (TTT) in Occult Choroidal Neovascularization (CNV) in Age-related Macular Degeneration (AMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00347906
Recruitment Status : Terminated (Difficulties in recruiting patients)
First Posted : July 4, 2006
Last Update Posted : January 12, 2010
Sponsor:
Information provided by:
University Hospital, Linkoeping

Tracking Information
First Submitted Date  ICMJE July 3, 2006
First Posted Date  ICMJE July 4, 2006
Last Update Posted Date January 12, 2010
Study Start Date  ICMJE November 2003
Primary Completion Date Not Provided
Current Primary Outcome Measures  ICMJE Not Provided
Original Primary Outcome Measures  ICMJE Not Provided
Change History Complete list of historical versions of study NCT00347906 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures  ICMJE Not Provided
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Photodynamic Therapy (PDT) Versus Transpupillary Thermotherapy (TTT) in Occult Choroidal Neovascularization (CNV) in Age-related Macular Degeneration (AMD)
Official Title  ICMJE Photodynamic Therapy Versus Transpupillary Thermotherapy in Occult CNV in Age-related Macular Degeneration
Brief Summary The purpose of this study is to compare the effect of PDT and TTT for the treatment of subfoveal occult CNV in age-related macular degeneration.
Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Condition  ICMJE Age-Related Macular Degeneration
Intervention  ICMJE Procedure: laser treatment
Study Arms  ICMJE Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Terminated
Enrollment  ICMJE Not Provided
Original Enrollment  ICMJE Not Provided
Study Completion Date  ICMJE September 2005
Primary Completion Date Not Provided
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • > 55 years of age,
  • Subfoveal occult only CNV due to AMD,
  • < 4 disc areas or > 4 disc areas
  • VA < 0.4

Exclusion Criteria:

  • Sign of classic CNV,
  • CNV in other diagnoses than AMD,
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 55 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Not Provided
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT00347906
Other Study ID Numbers  ICMJE Dnr 00052
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement  ICMJE Not Provided
Responsible Party Not Provided
Study Sponsor  ICMJE University Hospital, Linkoeping
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Principal Investigator: Christina I Frennesson, MD, PhD Linkoeping University
PRS Account University Hospital, Linkoeping
Verification Date November 2003

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP